SLDB
Solid Biosciences Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website olidbio.com
- Employees(FY) 87
- ISIN US83422E2046
Performance
-13.44%
1W
-8.86%
1M
-10.68%
3M
+229.04%
6M
+45.77%
YTD
+45.53%
1Y
Profile
Solid Biosciences Inc., a life science company, engages in developing therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, a next-generation gene transfer candidate for the treatment of Duchenne muscular dystrophy (Duchenne); AVB-202-TT, a gene therapy program for the treatment of Friedreich's ataxia; AVB-401, a gene therapy program for the treatment of BAG3-mediated dilated cardiomyopathy; and other drugs for the treatment of undisclosed cardiac diseases. It also engages in developing platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.
Technical Analysis of SLDB 2024-05-10
Overview:
In analyzing the technical indicators for SLDB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been consistently above the S...
Recent News & Updates
- 2024-05-15 00:53
SLDB Stock Earnings: Solid Biosciences Meets EPS for Q1 2024(Investorplace)
- 2024-05-14 19:52
- 2024-05-06 19:00
- 2024-05-02 04:05
- 2024-04-03 16:05
- 2024-04-03 04:05
- 2024-04-02 10:35
- 2024-04-01 22:35
- 2024-04-01 19:20
Solid Biosciences' SGT-003 receives rare pediatric disease designation(Pharmaceutical-business-review)
- 2024-04-01 07:45
- 2024-03-31 19:45
- 2024-03-28 16:08
How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback(Investor's Business Daily)
- 2024-03-27 07:00
- 2024-03-26 19:00
- 2024-03-13 07:44
- 2024-03-12 19:44
- 2024-03-07 07:00
- 2024-03-06 18:00
- 2024-03-06 08:00
- 2024-03-05 19:00
- 2024-02-29 03:02
14 Stocks With Heavy Insider Buying In 2024(Insider Monkey)
- 2024-02-28 14:02
14 Stocks With Heavy Insider Buying In 2024(Insidermonkey)
- 2024-01-18 10:21
- 2024-01-17 11:27
- 2024-01-16 22:27
- 2024-01-16 08:00
- 2024-01-16 00:10
- 2024-01-15 19:00
- 2024-01-15 10:18
- 2024-01-14 21:18
Page 1 of 5
previousnext